December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Vivek Subbiah: Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020
Dec 16, 2024, 12:28

Vivek Subbiah: Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on LinkedIn:

“Delighted to host a JAMA Oncology podcast on Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020.

Tune in for a Sunday morning drive and listen to my interview with Dr. Katrina A. B. Goddard, lead author of the paper published in JAMA Oncology.

Listen on Spotify or Apple Podcasts or wherever you get your podcasts, or via this link below American Medical Association Ed Hub.”

Listen here.

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer. He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials. He has also received the Yvonne Award 2024 by OncoDaily in the “Voice of Oncology” category.

More posts featuring Vivek Subbiah.